Dec 11, 2015 13:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2015 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today...
Dec 11, 2015 13:01 pm UTC| Business
AUSTIN, Texas, Dec. 11, 2015 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT), developer of True Human™ therapeutic antibodies, announced today a letter of agreement with the NCIC Clinical Trials Group (NCIC CTG) to...
Dec 11, 2015 13:01 pm UTC| Business
SAN ANTONIO, Texas, Dec. 11, 2015 (GLOBE NEWSWIRE) -- Cianna Medical, Inc. today announced that new data from an investigator-initiated trial evaluating the SAVI SCOUT surgical guidance system, an FDA-cleared tool for...
Flushing Financial Corporation to Speak to Institutional Investors
Dec 11, 2015 13:01 pm UTC| Business
UNIONDALE, N.Y., Dec. 11, 2015 (GLOBE NEWSWIRE) -- Flushing Financial Corporation (the "Company") (Nasdaq:FFIC), the parent holding company for Flushing Bank (the "Bank"), today announced that David Fry, the Company's...
Dec 11, 2015 12:31 pm UTC| Business
U.S. Commercial Launch Expected in the First Quarter of 2016 Webcast and Conference Call at 8:30 a.m. EST Today SAN DIEGO, Dec. 11, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company...
Galena Biopharma Announces Departure of Chief Financial Officer
Dec 11, 2015 12:06 pm UTC| Business
SAN RAMON, Calif., Dec. 11, 2015 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major...
Gino Santini and Daniel Welch Elected to Board of Directors of Intercept Pharmaceuticals
Dec 11, 2015 12:06 pm UTC| Business
NEW YORK, Dec. 11, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to...